Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects скачать в хорошем качестве

Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects

The demand for Mesenchymal Stem Cells (MSCs) has risen significantly over the past two decades due to their established immunomodulatory and tissue regenerative activities. They show therapeutic potential in treating inflammatory diseases and stimulating tissue repair after injury, as well as a starting source for cell therapy and as a drug delivery vehicle. REPROCELL has developed a new collection of iPSC-derived MSCs, and associated services and reagents to support MSC research projects. Through a partnership with Histocell, a leading European CDMO, our GMP manufacturing capabilities provide MSCs for use in clinical projects as well. In this webinar, we will introduce new PSC-derived MSCs, as well as services and reagents tailored to meet MSC research needs. We will also discuss the development of a CDMO for cell therapy production, the current infrastructure for GMP manufacturing of stem cells, and future perspectives for clinical MSCs. https://www.reprocell.com/ ____________________________________________________________________________ Follow us on LinkedIn:   / reprocell   Follow us on Twitter:   / reprocellglobal   ____________________________________________________________________________ Browse our product catalog: https://www.reprocell.com/product-cat... Got a research project you are looking to outsource? Contact our scientists to arrange a free consultation: https://www.reprocell.com/contact